DONOR-SPECIFIC SUPPRESSOR CELLS AND DONOR-SPECIFIC LOSS OF CELL-MEDIATED LYMPHOLYSIS IN RENAL-ALLOGRAFT RECIPIENTS - A COMPARATIVE-STUDY

被引:0
|
作者
MATHEW, M
KOVITHAVONGS, T
DOSSETOR, JB
机构
[1] UNIV ALBERTA,DEPT MED,CLIN & TRANSPLANTAT IMMUNOL GRP,EDMONTON T6G 2E1,ALBERTA,CANADA
[2] UNIV ALBERTA,DEPT LAB MED,EDMONTON T6G 2E1,ALBERTA,CANADA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1478 / 1480
页数:3
相关论文
共 50 条
  • [31] RENAL-ALLOGRAFT SURVIVAL IN PATIENTS WITH POSITIVE DONOR-SPECIFIC LYMPHOCYTE-B CROSSMATCHES
    NOREEN, H
    VANDERHAGEN, E
    SEGALL, M
    BACH, FH
    MORROW, C
    FRYD, D
    SUTHERLAND, D
    FERGUSON, R
    SIMMONS, R
    NAJARIAN, JS
    TRANSPLANTATION PROCEEDINGS, 1983, 15 (01) : 1216 - 1217
  • [32] Beneficial effects of donor-specific transfusion on renal allograft outcome
    Jovicic, Svetlana
    Lezaic, Visnja
    Simonovic, Ruzica
    Djukanovic, Ljubica
    CLINICAL TRANSPLANTATION, 2011, 25 (02) : 317 - 324
  • [33] Effect of De novo donor-specific antibodies on graft function in renal allograft recipients
    Singh, Ravi Kumar
    Gupta, Ashwani
    Bhargava, Vinant
    Gupta, Anurag
    Tiwari, Vaibhav
    Bhalla, Manish Malik A. K.
    Rana, D. S.
    Jain, Monika
    INDIAN JOURNAL OF TRANSPLANTATION, 2020, 14 (02) : 130 - 135
  • [34] TRANSPLANTATION Donor-specific HLA antibodies and renal allograft failure
    Loupy, Alexandre
    Jordan, Stanley C.
    NATURE REVIEWS NEPHROLOGY, 2013, 9 (03) : 130 - 131
  • [35] Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches
    Jordan, Stanley C.
    Vo, Ashley A.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2014, 19 (06) : 591 - 597
  • [36] A strategy to achieve donor-specific hyporesponsiveness in cadaver renal allograft recipients by donor haematopoietic stem cell transplantation into the thymus and periphery
    Trivedi, HL
    Vanikar, AV
    Vakil, JM
    Shah, VR
    Modi, PR
    Trivedi, VB
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (09) : 2374 - 2377
  • [37] C-REACTIVE PROTEIN - AN INDICATOR OF REJECTION EPISODE SEVERITY IN RENAL-ALLOGRAFT RECIPIENTS PRETREATED WITH DONOR-SPECIFIC TRANSFUSIONS
    LEMPERT, N
    FREED, B
    GODLEWSKI, J
    LAFFIN, R
    PIETROCOLA, D
    HAISCH, C
    CERILLI, J
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (01) : 662 - 664
  • [38] THE USE OF DONOR-SPECIFIC T-CELL LINES FOR MONITORING OF HUMAN ALLOGRAFT RECIPIENTS
    NIEDERWIESER, D
    IRSCHIK, E
    LEITER, E
    BINZ, H
    SPIELBERGER, M
    SCHONITZER, D
    MARGREITER, R
    HUBER, C
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) : 2587 - 2589
  • [39] BENEFICIAL-EFFECTS OF DONOR-SPECIFIC TRANSFUSIONS ON LONG-TERM RENAL-ALLOGRAFT FUNCTION
    ANDERSON, CB
    BRENNAN, D
    KELLER, C
    GOSS, J
    SHENOY, S
    BURTON, K
    SICARD, G
    FLYE, MW
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 991 - 994
  • [40] DIABETIC RENAL-ALLOGRAFT RECIPIENT PRETREATMENT WITH DONOR-SPECIFIC BLOOD PRODUCTS AND CONCOMITANT AZATHIOPRINE IMMUNOSUPPRESSION
    ANDERSON, CB
    SICARD, GA
    TYLER, JD
    RODEY, GE
    ANDERMAN, CK
    ETHEREDGE, EE
    TRANSPLANTATION PROCEEDINGS, 1984, 16 (03) : 633 - 635